|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61M 5/14 | |||
| A61F 2/02 | |||
| A61F 9/00 |
| (11) | Number of the document | 2207529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08830451.4 |
| Date of filing the European patent application | 2008-09-05 | |
| (97) | Date of publication of the European application | 2010-07-21 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/010487 |
| Date | 2008-09-05 |
| (87) | Number | WO 2009/035562 |
| Date | 2009-03-19 |
| (30) | Number | Date | Country code |
| 970699 P | 2007-09-07 | US | |
| 970709 P | 2007-09-07 | US | |
| 970820 P | 2007-09-07 | US | |
| 49317 | 2008-04-30 | US |
| (72) |
UTKHEDE, Deepank, CA
SHIMIZU, Robert W., US
JAIN, Rachna, US
BOYD, Stephen, US
GIFFORD, Hanson S., US
DE JUAN JR., Eugene, US
REICH, Cary J., US
|
| (73) |
Mati Therapeutics Inc.,
4317 Dunning Lane, Austin, TX 78746,
US
|
| (54) | DRUG CORES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS |
| DRUG CORES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS |